Virus Combination is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/singapore/infimh-16-0019/2016 Nib-104 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated); Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Adenovirus B Serotype 7 Strain 55142 Antigen; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 5; Human Herpesvirus 4; Hepatitis B Virus; Norwalk Virus.
| Product ID | 43742-1415_5d3c264c-0f40-46d4-a4bd-9118a3d3c172 |
| NDC | 43742-1415 |
| Product Type | Human Otc Drug |
| Proprietary Name | Virus Combination |
| Generic Name | Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-12-07 |
| Marketing End Date | 2024-04-16 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Deseret Biologicals, Inc. |
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HEPATITIS B VIRUS; NORWALK VIRUS |
| Active Ingredient Strength | 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL |
| NDC Exclude Flag | N |
| Marketing Start Date | 2018-12-07 |
| Marketing End Date | 2024-04-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-12-07 |
| Ingredient | Strength |
|---|---|
| INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) | 12 [hp_X]/mL |
| SPL SET ID: | ed7ce4b5-aff4-4294-837b-0be15de97ae5 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43742-1415 | Virus Combination | Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-1483 | Virus Combination | Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |
| 43742-1527 | Virus Combination | Influenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode |
| 43742-1586 | Virus Combination | Influenzinum (2019-2020), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode |
| 43742-1396 | Virus Plus | Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode |